Project Grant R24DA061178
Award Date
7/1/24
Completion Date
4/30/29
Dollars Obligated
$1.3M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
This $1,334,807 federal Project Grant award, with a period of performance from July 1, 2024 to April 30, 2029, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports the establishment and sustenance of a Patient Advisory Panel in Richmond, Virginia to facilitate collaboration between researchers and individuals in recovery from substance use disorder (SUD). The project aims to integrate patient perspectives...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will provide $188,525 to the University of Arkansas for Medical Sciences (UAMS) to develop and validate a patient-reported outcomes (PRO) survey instrument for evaluating new medications to treat methamphetamine use disorder (MUD). The proposed 2-year study will involve creating a conceptual framework, gathering stakeholder feedback, and assessing the...
This $1,272,788.38 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will establish the PRIDE-CARES Center to address gaps in substance use disorder (SUD) research and treatment for the sexual and gender minority (SGM) community. The key products and services to be delivered include: Developing a Virtual Patient Engagement Panel (VIP Panel) to actively engage patients, family members, and individuals in...
This $1,871,814 project grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will establish a Patient Engagement Resource Center (PERC) to address disparities in substance use disorder (SUD) treatment engagement for parents. The key products and services to be delivered through this 5-year award include: Forming a Lived Expertise Advisory Panel (LEAP) of 18 parents with SUD to support capacity building and...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $239,148 to develop and pilot a telehealth program integrated with syringe service programs (SSPs) to improve uptake and retention of pre-exposure prophylaxis (PrEP) and medication for opioid use disorder (MOUD) among people who inject drugs (PWID). The three-year project, which runs from September 15, 2024 to July 31, 2027, aims to address key...
This $267,696 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to enhance opportunities for addiction research at the University of Massachusetts Lowell (UML), a minority-serving institution located in the Merrimack Valley region. The key objectives are to: 1) Expand UML's undergraduate Public Health Informatics and Technology (PHIT) program with a new focus on applying data science to drug addiction research;...
This $1,393,769 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and assess a patient-centered approach to improve access to pre-exposure prophylaxis (PrEP), antiretroviral therapy (ART), and substance use disorder (SUD) services for persons who use drugs (PWUD) involved in the criminal justice system. The 5-year study, led by Yale University, will begin with a 1-year pilot in Connecticut to...
This $1,607,146 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development of community-based technology interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to substance use disorder treatment services. The recipient, NDRI-USA Inc., a non-profit research organization, will use a participatory design process to create multimedia content in English...
This National Institute on Drug Abuse (NIDA) Project Grant award for $1,126,100 aims to refine and pilot the R3 Supervision Strategy in substance use disorder (SUD) treatment programs. The funding, awarded under CFDA 93.279 - Drug Use and Addiction Research Programs, will enable the University of Arkansas for Medical Sciences (UAMS) to partner with SUD providers to modify and refine the evidence-based R3 supervision strategy for SUD settings. UAMS will then conduct two pilot cycles with 8...